Home › NDC Lookup › RxCUI directory › RxCUI 2058887

1 ML galcanezumab-gnlm 120 MG/ML Prefilled Syringe [Emgality] — RxCUI 2058887

RxNorm drug concept · Semantic branded drug
RxCUI 2058887 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2058887
Official name1 ML galcanezumab-gnlm 120 MG/ML Prefilled Syringe [Emgality]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asEmgality 120 MG per 1 ML Prefilled Syringe; Emgality 120 MG in 1 ML Prefilled Syringe
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)300,085 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Galcanezumab-gnlm Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — Emgality isn't a rescue medication you take when a migraine has already hit. It works as a preventive treatment, meaning you take it on a regular monthly schedule to reduce ho...
  • What exactly does Emgality do — does it stop a migraine once it starts?
  • Emgality comes as a prefilled pen or prefilled syringe — both are single-dose and deliver the full amount automatically. Before you inject, take it out of the fridge and let it sit...
  • How do I give myself this injection at home?
📖 Read our full Galcanezumab-gnlm Injection guide →

🕸️ Concept Web — How 1 ML galcanezumab-gnlm 120 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML galcanezumab-gnlm 120 MG/ML Prefilled Syringe [Emgality] RxCUI 2058887

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Galcanezumab 2058846
    • Galcanezumab-gnlm 2058868
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Emgality 2058873
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Galcanezumab Prefilled Syringe 2058884
    • Galcanezumab-gnlm Prefilled Syringe 2646611
    • Galcanezumab Injectable Product 2058870
    • Galcanezumab-gnlm Injectable Product 2661888
    • Galcanezumab Prefilled Syringe [Emgality] 2058886
    • Galcanezumab-gnlm Prefilled Syringe [Emgality] 2656925
    • Emgality Injectable Product 2058876
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML galcanezumab-gnlm 120 MG/ML Prefilled Syringe SCD · 2058885
  • Galcanezumab-gnlm 120 MG/ML SCDC · 2058869
  • Galcanezumab Prefilled Syringe SCDF · 2058884
  • Galcanezumab-gnlm Prefilled Syringe SCDFP · 2646611
  • Galcanezumab Injectable Product SCDG · 2058870
  • Galcanezumab-gnlm Injectable Product SCDGP · 2661888

Brand-Name Concepts

  • Galcanezumab-gnlm 120 MG/ML [Emgality] SBDC · 2058874
  • Galcanezumab Prefilled Syringe [Emgality] SBDF · 2058886
  • Galcanezumab-gnlm Prefilled Syringe [Emgality] SBDFP · 2656925
  • Emgality Injectable Product SBDG · 2058876
  • Emgality BN · 2058873

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2058887 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00002-1436-11 1 SYRINGE in 1 CARTON (0002-1436-11) / 1 mL in 1 SYRINGE (0... EMGALITY Eli Lilly and Company 2018-09-27
00002-1436-61 2 SYRINGE in 1 CARTON (0002-1436-61) / 1 mL in 1 SYRINGE EMGALITY Eli Lilly and Company 2018-09-27
00002-2377-11 1 SYRINGE in 1 CARTON (0002-2377-11) / 1 mL in 1 SYRINGE (0... EMGALITY Eli Lilly and Company 2019-01-18
00002-3115-09 3 SYRINGE in 1 CARTON (0002-3115-09) / 1 mL in 1 SYRINGE (0... EMGALITY Eli Lilly and Company 2019-06-17
Observed labelers: Eli Lilly and Company (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.